Sign up for a new account.
And get access to
The latest T1D content
Research that matters
Our daily questions
Sign up by entering your info below.
Sign in to your account with
Reset Your Password
We will email you instructions to reset your
Background/Objective: Continuous glucose monitoring (CGM) use is associated with improved outcomes in type 1 diabetes, but racial-ethnic disparities in use exist. We initiated targeted interventions to improve CGM prescriptions in our medical center among racial-ethnic minority populations and examined rates over time.
Methods: From January 2019 to August 2021, we developed a specialty clinic for type 1 diabetes, expanded provider awareness of inequity and training in CGM, and improved prescribing workflows. As a participating site of the T1D Exchange Quality Improvement Collaborative (T1DX-QI), we collected monthly aggregate data over the intervention period using the electronic medical record. We calculated CGM prescription rates with the numerator representing number of people prescribed CGM in the reporting month and the denominator representing number of total patients seen by endocrinology in the same month. We performed ANOVA testing to examine differences by race-ethnicity over time.
This site uses Akismet to reduce spam. Learn how your comment data is processed.
Improvement in equity of CGM prescriptions after targeted interventions
You must be logged in to post a comment.